95 results
Page 5 of 5
424B5
k6oo3ut5
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-10.1
hvx08693d 5nls18
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
F-3/A
EX-4.2
fij02kn2p2 gsko5v
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
D
auagc rzikdj1s97pds
9 Apr 19
$2.25M in options, sold $2.25M, 8 investors
9:04am
424B5
qnwrhdth
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
EX-10.1
qniktl
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
EX-99.1
6trls
17 Jan 19
Annual General Meeting of Shareholders
4:05pm
6-K
EX-99.1
1hwx4ik5ndg0wd
28 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:27am
6-K
EX-10.1
n5tow gri2
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
F-3
EX-4.3
7s9k1dn
20 Jun 18
Shelf registration (foreign)
2:38pm
F-3
EX-4.4
q4a6qyossueb
20 Jun 18
Shelf registration (foreign)
2:38pm
20-F
mj7yy 37r
1 May 17
Annual report (foreign)
12:00am
20-F
EX-4.3
ql0 pn50ud0cgdnlmoh
1 May 17
Annual report (foreign)
12:00am